SCHEMBL2567446

SCHEMBL2567446

CN1CCc2ccc(NC(=O)[C@H](N)CC3CCCCC3)cc2CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AAK1 Q2M2I8 3/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
HPGD P15428 2/20 0.49
NPC1 O15118 2/20 0.49
RAB9A P51151 2/20 0.49
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2D6 P10635 1/20 0.49
CYP2C19 P33261 1/20 0.49
CIT O14578 2/20 0.44
ALOX15 P16050 2/20 0.42
HTT P42858 1/20 0.42
METAP2 P50579 1/20 0.41
METAP1 P53582 1/20 0.41
MAPK1 P28482 1/20 0.41
KDM4E B2RXH2 2/20 0.40
ALDH1A1 P00352 2/20 0.40
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40
TP53 P04637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2570332 0.79 KDM4E (0.47) AAK1SMN1; SMN2HPGDNPC1RAB9A
SCHEMBL13069897 0.79 PPM1D (0.41) SMN1; SMN2HPGDNPC1RAB9ACYP1A2
SCHEMBL8252759 0.78 F10 (0.45)
SCHEMBL2571662 0.78 F10 (0.45)
SCHEMBL2573167 0.78 ALOX15 (0.44) SMN1; SMN2HPGDNPC1RAB9AALOX15
SCHEMBL2569655 0.78 HPGD (0.41) SMN1; SMN2HPGDNPC1RAB9ACYP3A4
SCHEMBL2567550 0.77 POLB (0.46) SMN1; SMN2HPGDNPC1RAB9AALOX15
SCHEMBL2563694 0.77 ALOX15 (0.43) AAK1SMN1; SMN2HPGDRAB9ACYP3A4
SCHEMBL2571876 0.77 ROCK2 (0.48) AAK1NPC1RAB9AALDH1A1KMT2A
SCHEMBL2570020 0.77 KDM4E (0.48) AAK1HPGDNPC1RAB9ACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1899330-B9 SUBSTITUTED GLYCINAMIDES HAVING AN ANTITHROMBOTIC AND FACTOR XA-INHIBITING EFFECT BOEHRINGER INGELHEIM INT (DE) 2011-11-09 EP claimed
EP-1899330-B1 SUBSTITUTED GLYCINAMIDES HAVING AN ANTITHROMBOTIC AND FACTOR XA-INHIBITING EFFECT BOEHRINGER INGELHEIM INT (DE) 2010-11-24 EP claimed